Valade, Elodie <br/><br/>
Population Pharmacokinetics of AL-335 and Its Two Main Metabolites (ALS-022399, ALS-022227) in Monotherapy and in Combination with Odalasvir and/or Simeprevir.  [electronic resource] 

 -  The AAPS journal  10 2018 
 - 1 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1550-7416 
<br/><br/><label>Standard No.: </label>10.1208/s12248-018-0272-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Alanine--administration & dosage<br/>Antiviral Agents--administration & dosage<br/>Benzimidazoles--administration & dosage<br/>Biological Variation, Population<br/>Carbamates--administration & dosage<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Drug Therapy, Combination--methods<br/>Healthy Volunteers<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Indoles--administration & dosage<br/>Phosphoramides<br/>Simeprevir--administration & dosage<br/>Uridine--administration & dosage